NDC 0002-3444-11
Mounjaro KwikPen 12.5 mg/mL
tirzepatide · INJECTION, SOLUTION
Mounjaro KwikPen is a injection, solution containing tirzepatide at a strength of 12.5 mg/mL. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Mounjaro KwikPen
- Generic Name
- tirzepatide
- NDC Code (Package)
0002-3444-11- NDC Code (Product)
0002-3444- Manufacturer
- Eli Lilly and Company
- Strength
- 12.5 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA215866
- Drug Class
- Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]; GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 01/20/2026
Recall History
No Recall HistoryView Full Drug Page
Mounjaro KwikPen — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.